🚨Our June issue is LIVE🚨 How much does a day of delay in a clinical trial really cost?🔺Aligning patient burden with planetary burden🔺Guiding principles for trial participant communication🔺and so much more right here ➡️ https://lnkd.in/ej4vGbZv
Applied Clinical Trials Magazine
Book and Periodical Publishing
Iselin, New Jersey 14,628 followers
"Your Trusted Clinical Trials Management Resource"
About us
Applied Clinical Trials magazine is the authoritative, peer-reviewed resource and thought leader for the global community that designs, initiates, manages, conducts, and monitors clinical trials. Industry professionals learn effective and efficient solutions to strategic and tactical challenges within the tightly regulated, highly competitive pharmaceutical environment. Our global, peer-reviewed journal's coverage features the process of managing clinical trials at the intersection where pharmaceutical product developers meet the strictly regulated medical researchers who test their new drugs.
- Website
-
http://www.appliedclinicaltrialsonline.com
External link for Applied Clinical Trials Magazine
- Industry
- Book and Periodical Publishing
- Company size
- 11-50 employees
- Headquarters
- Iselin, New Jersey
- Type
- Public Company
- Founded
- 1992
- Specialties
- Publishing, Clinical Trials Resource, and Peer-Reviewed Articles
Locations
-
Primary
Iselin, New Jersey 08830, US
Employees at Applied Clinical Trials Magazine
Updates
-
Applied Clinical Trials Magazine reposted this
In her latest interview with Applied Clinical Trials Magazine, our VP, Clinical Data Management Diane Lacroix discusses the greatest benefits of integrating #AI into data management. 🎬 Watch the full interview with Andy Studna here: https://lnkd.in/gDyYxACK "Being able to utilize #AI for our data cleaning and data processing...truly reduces the overall effort of looking at large volumes of data, stripping away what is not important, what the model deems as acceptable, and allowing us to focus only on what's absolutely critical and anomalous. This really does reduce time and effort. It allows us also to identify risks sooner in the process." #clinicaltrials #lifesciences #clinicaldata #interview #pharma
-
-
Applied Clinical Trials Magazine reposted this
I had the honor of discussing key themes at #DIA2024 with Applied Clinical Trials Magazine. What were your favorite sessions? Share in the comments!
-
📹 In part 3 of this video interview, Carie Pierce, SVP, global head of growth & business development, DIA highlights the most relevant themes related to #clinicaltrials that were present at #DIA2024 including DE&I and #patientrecruitment
Themes Involving Clinical Trials at the 2024 DIA Global Annual Meeting
appliedclinicaltrialsonline.com
-
Dovato regimen met its primary endpoint at 48 weeks for the treatment of HIV-1 in people who are virologically suppressed.
Dovato Demonstrates Non-Inferior Efficacy to Biktarvy in Head-to-Head Phase IV Trial
appliedclinicaltrialsonline.com
-
Carie Pierce shares her greatest takeaways from this year's #DIA2024 meeting in San Diego, CA.
DIA Global Head of Growth, Carie Pierce Discusses 2024 Global Annual Meeting
appliedclinicaltrialsonline.com
-
#Paxlovid was the first oral drug approved by the FDA to treat #COVID19 in adults who do not require supplemental oxygen and who have an increased risk of progression to severe disease
Paxlovid Postexposure Prophylaxis Not Found to Significantly Lower Risk of Symptomatic SARS-CoV-2
appliedclinicaltrialsonline.com
-
Applied Clinical Trials Magazine reposted this
The best place to start with #recruitment and #retention is with what employees *really* want. What other data-based insights can you learn from the report we made with Applied Clinical Trials Magazine? Download a FREE copy to find out: https://ow.ly/rsyn50QZb0F
-
-
Check out our upcoming featured webcasts from Applied Clinical Trials®! #PatientTechnology #ClinicalTrials #ClinicalResearch
July's Featured Webcasts
Applied Clinical Trials Magazine on LinkedIn
-
The androgen receptor inhibitor significantly increased radiological progression-free survival in combination with androgen deprivation therapy compared to placebo.
NUBEQA Meets Primary Endpoint for Phase III ARANOTE Trial in Men with Prostate Cancer
appliedclinicaltrialsonline.com